Hamidovic Ajna
College of Pharmacy, University of Illinois Chicago, Chicago, IL 60607, USA.
J Clin Med. 2025 Jun 23;14(13):4438. doi: 10.3390/jcm14134438.
Due to the low certainty of existing evidence, no formal recommendation can be made for or against the use of antipsychotics over usual care in ICU patients with delirium. To advance evidence-based practice, we used observational data from the Medical Information Mart for Intensive Care (MIMIC) to estimate the effect of pre-ICU quetiapine treatment (vs. control) on the length of ICU stay. In a second, head-to-head comparison, we assessed quetiapine vs. haloperidol on the same outcome. We conducted two propensity score-matched procedures: 518 patients were matched based on receipt of quetiapine versus no antipsychotic (i.e., control), and 336 patients based on quetiapine versus haloperidol prior to ICU admission. After matching, we performed Bayesian generalized additive modeling (GAM) and Bayesian sensitivity analyses within a nonlinear modeling framework. In the quetiapine versus no quetiapine analysis, the original overall covariate distance of 0.48 was reduced to 0.01 post-matching. All covariates achieved an acceptable balance, with absolute standardized mean differences below 0.1. Quetiapine use was associated with a 1.31-day longer ICU stay (posterior mean = 0.36; 95% credible interval: 0.14 to 0.59). Sensitivity analyses indicated that this effect remained robust after accounting for plausible levels of unmeasured confounding. In the quetiapine versus haloperidol analysis, the initial overall distance of 0.40 was reduced to 0.09 after matching, with all covariates similarly balanced. Compared to haloperidol, quetiapine treatment was associated with a 1.46-day longer ICU stay (posterior mean = 0.48; 95% credible interval: 0.09 to 0.88). Bayesian sensitivity analyses again indicated the robustness of the effect estimate. In these emulated clinical trials, pre-ICU treatment with quetiapine was associated with a prolonged ICU stay compared to both untreated and haloperidol conditions. Though more research in this field is needed, these findings do not support the use of quetiapine in ICU patients with delirium.
由于现有证据的确定性较低,因此无法就是否在患有谵妄的重症监护病房(ICU)患者中使用抗精神病药物优于常规治疗给出正式建议。为了推进循证实践,我们使用了重症监护医学信息集市(MIMIC)的观察数据来估计ICU前使用喹硫平治疗(与对照组相比)对ICU住院时间的影响。在第二项直接比较中,我们评估了喹硫平和氟哌啶醇对相同结局的影响。我们进行了两种倾向评分匹配程序:518名患者根据是否接受喹硫平与未接受抗精神病药物(即对照组)进行匹配,336名患者根据ICU入院前是否接受喹硫平与氟哌啶醇进行匹配。匹配后,我们在非线性建模框架内进行了贝叶斯广义相加模型(GAM)和贝叶斯敏感性分析。在喹硫平与未使用喹硫平的分析中,匹配前的原始总体协变量距离为0.48,匹配后降至0.01。所有协变量都达到了可接受的平衡,绝对标准化均值差异低于0.1。使用喹硫平与ICU住院时间延长1.31天相关(后验均值=0.36;95%可信区间:0.14至0.59)。敏感性分析表明,在考虑了合理水平的未测量混杂因素后,这种效应仍然稳健。在喹硫平与氟哌啶醇的分析中,匹配前的初始总体距离为0.40,匹配后降至0.09,所有协变量同样平衡。与氟哌啶醇相比,喹硫平治疗与ICU住院时间延长1.46天相关(后验均值=0.48;95%可信区间:0.09至0.88)。贝叶斯敏感性分析再次表明效应估计的稳健性。在这些模拟临床试验中,与未治疗和氟哌啶醇治疗的情况相比,ICU前使用喹硫平与ICU住院时间延长有关。尽管该领域还需要更多研究,但这些发现不支持在患有谵妄的ICU患者中使用喹硫平。